Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» UCB’s epilepsy drug approved as monotherapy in US
UCB’s epilepsy drug approved as monotherapy in US
UCB’s epilepsy drug approved as monotherapy in US
Submitted by
admin
on September 2, 2014 - 8:09am
Source:
Pharmaphorum
News Tags:
UCB Pharmaceuticals
FDA
epilepsy
Vimpat
Headline:
UCB’s epilepsy drug approved as monotherapy in US
Do Not Allow Advertisers to Use My Personal information
